NCT00400556
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Cutaneous Lymphoma, +18 more
- Locations
-
- Peter MacCallum Cancer Center East Melbourne, Victoria, Australia
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
1,676 public trials
321 recruiting studies
Multiple Myeloma trial results
NCT00037791
- Conditions
- Blood Platelet Disorders, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Pfizer Investigational Site Berkeley, California, United States
- Pfizer Investigational Site La Jolla, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
NCT00300664
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +23 more
- Locations
-
Not specified
NCT00378222
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
Not specified
NCT00367185
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Lille University Hospital Lille, France
Completed
A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma
NCT00096837
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
NCT00323505
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Royal Marsden NHS trust Sutton, Surrey, United Kingdom
NCT00301275
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Royal Marsden NHS trust Sutton, Surrey, United Kingdom
NCT00078065
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Oncotherapeutics Los Angeles, California, United States
- University of California, San Diego San Diego, California, United States
- University of California, San Francisco San Francisco, California, United States
- Johns Hopkins Medical Institute Baltimore, Maryland, United States
Completed
Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma
NCT00036140
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Research Center Los Angeles, California, United States
- Research Center Los Angeles, California, United States
- Research Center Rancho Mirage, California, United States
- Research Center Cleveland, Ohio, United States